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ABSTRACT The kinetics of insulin-basedamyloid gel formation has been studied using extinction and ﬂuorescence detection. The
process is treated as autocatalytic, and the kinetic proﬁles are ﬁt using a nonconventional analysis involving a time-dependent rate
constant (factor): k(t )¼ ko1 kc(kct )n. Thedependenceof the kinetic parameterson initial solutionconditions of concentration, pH, and
ionic strength has been investigated. A mechanism is proposed in which the rate-determining step involves the activation of insulin
solute species into partially unfolded, structurally modiﬁedmonomers, which then aggregate. The inﬂuence of addedmetalloporphyrins
on the rate and extent of gel formation is described. Metal derivatives of tetrakis(4-sulfonatophenyl)porphine prove effective at
inhibiting the aggregation of insulin via pathways that depend on concentration and identity of the incorporated metal.
INTRODUCTION
The current intense interest in protein misfolding and aggre-
gation is linked in large part to the role these processes play
in human and animal diseases (1–4). In general for prion
diseases, a conversion from the correctly folded native state
of the protein to a structure rich in b-sheets is involved in the
production of pathological forms (4,5). The population of
structurally converted protein molecules recruits and induces
conversion of other molecules, which then aggregate to form
insoluble plaques (6). Deposits of these plaques in the brain
are the hallmark of scrapie, Alzheimer’s disease, Creutzfeld-
Jakob disease, and bovine spongiform encephalopathy. The
plaques, though composed of different proteins depending on
the disease, share a common general structure, termed
‘‘amyloid’’.
It has recently been shown that amyloid formation is not
a phenomenon restricted to a select group of proteins but that
many (if not all (7)) naturally occurring polypeptides can
form such oriented assemblies under conditions that de-
stabilize the native structure but still favor noncovalent
interactions. This requirement is met when bovine pancreatic
insulin is heated under acidic conditions (8,9). Although
insulin is not directly involved in amyloid-based pathogen-
esis, it provides several advantages when used as a source for
investigations of amyloid-type aggregate formation. First,
insulin is inexpensive and readily available commercially.
Second, it is a well-characterized peptide whose structure,
sequence, and properties are well known. Third, insulin
b-amyloid-type aggregates can be produced in a standard
laboratory setting without the use of specialized equipment
(9). Fourth, insulin b-amyloids behave chemically much like
b-amyloids derived from proteins implicated in various
disease states as evidenced by gel structure and interactions
with Congo red (CR) and Thioﬂavin T (Thio T) (10–12).
Thio T and CR provide unique spectral features when bound
to Ab arrays (ﬁbrils), interactions that depend upon aggre-
gate morphology and the regularity of the cross-b-structure
characteristic of these species. Absorption and ﬂuorescence
results suggest very similar structures for insulin gels and Ab
ﬁbrils (supplementary Fig. S1); electron micrographs and
x-ray diffraction studies conﬁrm this conclusion (13).
Insulin is a 51-residue protein consisting in its native state
of two peptide chains linked by two disulﬁde bridges. Crys-
talline insulin is a hexamer, with three insulin dimers coor-
dinated to two Zn21 ions, although the number of zinc ions
per hexamer has been reported as ranging from two to four
(14). Conformational studies have shown insulin to be rich in
a-helical motifs but acid causes dissociation of the insulin
hexamer with subsequent change in conformation at elevated
temperatures to enable aggregates to form (13–17). The pu-
tative series of events leading to the formation of amyloid-
type gels begins, therefore, with acidiﬁcation of insulin; at
pH; 2 in HCl, the peptide is largely dimeric (15). The dimer
dissociates at high temperature producing a partially un-
folded monomer (18,19), which aggregates to form thermo-
dynamically favorable protoﬁlaments (protoﬁbrils) (20,21).
These protoﬁbrils have been reported as being short, rather
ﬂexible species, generally 4–10 nm in diameter and up to
;200 nm in length (22). Protoﬁbrils are in turn precursors of
the longer, more rigid, amyloid-type ﬁbrils of the type
generally associated with Alzheimer’s disease (14,20–22).
The motivation for this study is: i), to examine the kinetics
and mechanism of ﬁbril formation; ii), to determine the
impact of changes in solution conditions on the rate of the
process; and iii), to examine various substances as potential
catalysts or inhibitors of b-amyloid formation. For this
analysis we have applied an autocatalytic kinetic model (23–
25) that has been developed for assembly processes in which
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an array surface catalyzes the rate-determining formation of
a critical ‘‘nucleus’’ or ‘‘seed’’, comprised ofm reactant units.
The distinctive feature of this model is a time-dependent rate
constant (‘‘rate factor’’) that reﬂects catalysis by a growing
surface (in this instance, the protein assembly):
kt ¼ k01 kcðkctÞn; (1)
where ko and kc are time-independent constants (both having
units of s1) for the uncatalyzed and catalyzed aggregation,
respectively. The time-dependence parameter n is related to
the growth rate of the activating surface. The integrated rate
law for this model is given by:
½At ¼ ½AN1 ð½A0  ½ANÞ=ð11 ðm 1Þ
3fk0t1 ðn1 1Þ1ðkctÞn1 1gÞ
1
m1; (2)
where [A] represents the aggregated or assembled insulin
units and m 6¼ 1. For the special case in which m ¼ 1 (which
corresponds to activation of the unassembled, initial solute
species by the array surface as the rate-determining step), the
equation takes on a more familiar form referred to as a
‘‘stretched exponential’’ (24):
½At ¼ ½AN1 ð½A0  ½ANÞexpðk0t  ðkctÞn1 1=n1 1Þ:
(3)
(Notice that for n ¼ 0, Eq. 3 reverts to a simple expo-
nential form).
The autocatalytic model (Eq. 2) has been applied with
considerable success to porphyrin-assembly kinetic data (23–
25), and it proves effective at ﬁtting literature data for a
number of biological/pathological growth processes includ-
ing the polymerization of actin (23,24); the aggregation of
hemin to produce themalaria pigment, hemozoin (26); and the
formation of b-amyloids by fragments of the OsmB protein.
However, the kinetic study for this last system (27) does not
provide closely spaced data points, and therefore, conclusions
based on these data are at best tentative. In particular, from the
preliminary analysis, the autocatalytic model predicts that the
seed size for OsmB aggregation is very small, approaching
unity. It is clear that if more deﬁnitive mechanistic arguments
concerning amyloid formation are to bemade, precise data are
needed. Studying the mechanism of protein aggregation with
model systems can, in principle, contribute to a better under-
standing of themolecular mechanisms involved in the disease
state (28,29) and, with this goal in mind, we embarked on this
kinetic study involving bovine pancreatic insulin. This report
includes the results of that investigation along with our
ﬁndings on the inﬂuence of pH andmetal ion concentration on
the rate of aggregation, and also includes the effect of several
water-soluble metalloporphyins on insulin gel formation.
EXPERIMENTAL
Materials
Crystalline bovine pancreatic insulin was obtained from Sigma (St. Louis,
MO), stored with a dessicant below 0C, and used without further
puriﬁcation. Concentrations of insulin solutions were determined using
a molar absorptivity of 6040 M1cm1 at 278 nm (30). Thio T and CR
obtained from Sigma were used to prepare stock solutions on the day of use.
The free base porphyrins, tetrakis(N-methylpyridinium-4-yl)porphine
(H2T4
41) and tetrakis(4-sulfonatophenyl)porphine (H2TPPS
4) were pur-
chased from MidCentury Chemical (Posen, IL) as the chloride and sodium
salts, respectively. Metalloporphyrin derivatives were synthesized by
literature methods (see Table 1 references, below). Their concentrations
were determined using molar absorptivity values available in the literature.
All other reagents were of the highest purity available from Fisher Scientiﬁc
(Hampton, NH) and Sigma/Aldrich. Solutions were prepared using ultra-
puriﬁed water that had been passed through a 0.2-mm Nalgene ﬁlter and
degassed.
Instruments
Extinction measurements and absorbance spectra were recorded with Jasco
(Easton, MD) V-550 and V-560 ultraviolet-visible (UV-Vis) spectrophotom-
eters. Fluorescence and some scattering measurements were conducted with
a Spex Fluorolog 3 ﬂuorimeter. Simultaneous extinction and ﬂuorescence
measurements were made using a modiﬁed QuantaMaster ﬂuorescence
system from Photon Technology (Birmingham, NJ). An additional
photodetector was installed in line with the excitation beam to allow for
intensity measurements. Because there is no second monochromator in the
forward direction, narrow-band-pass ﬁlters (394 nm maximum, 10 nm full
width half-maximum)were placed before and after the sample in the direction
of the excitation beam to eliminate the effect of ﬂuorescence at longer
wavelengths on the extinction measurements. Also, a neutral density ﬁlter
(Edmund Optics, Barrington, NJ) was placed in front of the additional photo-
detector to decrease the light intensity reaching it, thereby allowing slits to be
opened to a convenient size. The optical conﬁguration of this instrument
involves a focused rather than collimated beam for extinction measurements.
Methods: insulin gel preparation
The method of Burke and Rougvie was used to prepare large quantities of
amyloid-type insulin gels (9). The amyloid nature of the gels was conﬁrmed
using criteria previously established involving interactions with Thio T and
CR (10–12). Recent work has shown that a combination of heating and
freezing steps yields a great diversity of ﬁbrils with different structures and
spacings. In contrast, when an insulin sample is simply heated to ;60C
near pH 2 (as in the protocol described below) only a single type of compact
ﬁbril forms (21).
Standard kinetics protocol
Details of preparation and treatment of reactant solutions need to be
documented to permit direct comparisons of experimental results from
different laboratories. In the procedure used here, a reaction mixture
containing the desired concentrations of reagents other than insulin was
TABLE 1 Molar absorptivities of porphyrin derivatives
Ligand
Derivative
T4 lmax
(nm)
el
(3 105 M1cm1)
TPPS lmax
(nm)
el
(3 105 M1cm1)
Cu(II) 425 2.31 412 4.16
Ni(II) 420 1.49 409 ;2
Fe(III) 401 1.02 394 1.52
Mn(III) 462 0.92 467 0.95
Co(III) 434 2.14 425 2.38
Au(III) 404 2.82 405 4.37
T4, tetrakis(N-methylpyridinium-4-yl)porphine; TPPS, tetrakis(4-sulfona-
tophenyl)porphine). (Table references (39–47)).
1034 Pasternack et al.
Biophysical Journal 90(3) 1033–1042
prepared in a disposable methacrylate cuvette. The resulting solution was
thermally equilibrated at a preselected temperature (generally 67.4C) in the
cuvette block of a spectrophotometer or ﬂuorimeter. The precise temperature
was determined using a Thermolyne thermocouple. A fresh stock solution of
;3 mM insulin in 0.056 M HCl was prepared daily. A small volume of this
stock was added to the thermally equilibrated reaction mixture to produce the
target insulin concentration and pH, with a total volume of 3 mL. The cuvette
was capped, inverted twice, and returned to the cuvette block for data
collection. Because the stock insulin was at room temperature when added to
the thermally equilibrated solution, this mixing method gives a slight
uncertainty in the initial temperature. However, the volume delivered was
relatively small and the transfer was done very quickly, generally within 3 s.
The rate of the aggregation process proves to be dependent not only on
the preparation and mixing protocol but on size and shape of foreign objects,
e.g., magnetic stir bars, included in the reactor. In addition, stirring speed,
and cuvette topology have an impact on the kinetics of gel formation as
reported in a previously published study in which the rate of ﬁbril formation
was signiﬁcantly increased by stirring (31). To avoid some of these
complications, we employed a vortex mixer to agitate the reaction mixture.
The sample was vigorously agitated for a very brief period every 200 s so as
not to interfere with data collection. The timescale for the reaction proﬁle for
this experiment involving periodic, thorough mixing of reagents and that of
an experiment in which there was no stirring of the reagents are virtually
identical. The kc, m, and n values (see Introduction) each agreed to within
10%. The major difference between the two proﬁles is the total turbidity of
the mixture at the end of the reaction, with the vortexing method producing
the more turbid sample (supplementary Fig. S2). Although the ﬁnal
extinction values differ, the close agreement of the kinetic parameters led us
to employ as a standard protocol one in which the reagents are mixed to
initiate the experiment (as described above) and then allowed to react un-
stirred. This protocol provided the most self-consistent results of the various
methods attempted and avoids the potential difﬁculties inherent in mechan-
ical agitation of the forming gel and surface effects arising from the presence
of a stirrer. It also avoids the necessity of scrupulously cleaning stir bars to
avoid contamination by inadvertent ‘‘seeding’’ of reaction mixtures.
Data analysis
A minimum of 98% of the total extinction change for each kinetics
experiment was ﬁt using the model described in the Introduction. The data
for some runs were truncated to 98% to avoid complications arising from
multiple, forward scattering of highly turbid samples (vide infra) or settling
of the gel. Data were ﬁt to either Eq. 2 or Eq. 3 given above, depending upon
the value of the nucleus size parameter m. We also attempted to ﬁt our
kinetic data using an alternative model proposed by Sabate´ et al. for ag-
gregation of the amyloid protein Ab (32). We found that in most cases the
Sabate´ model provided a ﬁt equivalent to that of this model. However,
autocatalytic proﬁles that were recorded at low pH or concentration, or that
have seed sizes .1–1.5 (23–25) are better ﬁt with this model, and, therefore,
because of its broader applicability, the kinetic approach described here was
used consistently for all kinetic runs.
Two detection modes were employed for kinetic studies of insulin
gelation. In one, the time dependence of scattering of the system was de-
termined (usually at a 0 detection angle although a few studies were con-
ducted at 90 for comparison). Alternatively, ﬂuorescence detection was
used, which takes advantage of the enhanced quantum efﬁciency for
Thioﬂavin T emission when interacting with amyloid structures (12). These
two detection modes complement one another in that Thio T ﬂuorescence
enhancement occurs as the ﬂuorophore recognizes protoﬁbril species that are
formed en route to the ﬁnal aggregation product (22) whereas scattering is
sensitive not only to the number density of the scatterer but also the size of
the object. Hence, this latter method is biased toward the largest objects
(ﬁbrils) that form.
Using extinction at a nonresonance wavelength to follow kinetic events is
not as straightforward as are most commonly employed detection methods.
Scattering intensity depends on the size and shape of the scattering object
(angle dependent) as well as its number density and, in a kinetic process
these features will change with time. However, extinction measurements at
0 provide, in effect, information on the total scattering at all angles (other
than in the forward direction) through a single measurement. Therefore, this
would appear to be the optimum angle for such kinetic studies. This choice
needs to be tested for each system and instrument—the cone angle of photon
detection is ﬁnite, and forward scattering could change appreciably during
the course of the reaction. We performed a number of experiments to test
whether such scattering measurements are reliable for this system under the
conditions used. To assess the limits of applicability of these measurements,
two aspects of the Beer-Lambert law were considered. In one, a serial dilu-
tion of vortexed, preformed gel (9) was carried out and the extinction in the
visible range was determined. Extinction in this wavelength range is due to
scattering only because there is no absorbance component. Plots of ex-
tinction versus volume of added gel proved linear up to an extinction of ;1
(supplementary Fig. S3 a). The Beer-Lambert law also predicts that
extinction will vary linearly with pathlength, although appreciable multiple
and/or forward scattering could result in deviations from linearity. The
extinction of an insulin gel suspensionwas recorded in cuvettes with pathlengths
varying from 1 to 10 mm; there is no signiﬁcant deviation from linearity in
the plot (supplementary Fig. S3 b). Therefore, we conclude that any time-
dependent change in forward scattering is of little signiﬁcance for this
system under the conditions of our experiments, and that extinction mea-
surements on a UV-Vis spectrophotometer—where the detection angle is
near 0—are appropriate for kinetic analyses of gel formation. To investigate
the possibility that time-dependent scattering proﬁles and, therefore kinetic
parameters, may vary with detection angle, extinction measurements were
made for insulin aggregation using a UV-Vis spectrophotometer and a
ﬂuorimeter, detecting at 0 and 90 to the incident light, respectively. The
analysis of the kinetic proﬁles yielded kinetic parameters in good agreement
but the signal/noise ratio was considerably more favorable for the spec-
trophotometric measurements. The close agreement between the two sets of
rate constants in these experiments conducted at different detection angles is
a result of considerable importance for studies to be described below in the
Results section.
RESULTS
A kinetic proﬁle for insulin gel formation involving extinc-
tion measurements at 488 nm is shown in Fig. 1. None of the
reaction components absorb light at this wavelength so the
increase in signal with time corresponds to enhanced light
scattering by the sample. The initial conditions were 200 mM
insulin at pH 1.37, 67C. The proﬁle is shown in Fig. 1 along
with the ﬁt obtained by application of the autocatalytic
model, Eq. 2. Because of the insigniﬁcant slope of the initial
portion of the kinetic proﬁle, a reliable value of ko could not
be estimated but kc ¼ 3.8 3 104 s1; n ¼ 11 and m ¼ 1.4.
A second method of detection for insulin gel formation
involves monitoring the ﬂuorescence of added Thioﬂavin T
with time. An isosbestic point for Thio T when free in
solution and when gel-bound was determined at 3956 3 nm,
the wavelength used for excitation of the ﬂuorophore. Our
preliminary experiments focused on whether the addition of
10 mM Thio T to the reaction mixture has an impact on the
aggregation kinetics as detected via extinction measure-
ments. The agreement among kinetic parameters for gelling
with and without added Thio T was within experimental
error, and no systematic variation of these parameters was
Formation Kinetics of Amyloid Gels 1035
Biophysical Journal 90(3) 1033–1042
found in multiple runs. We conclude that under the con-
ditions of our experiments, the presence of low concen-
trations of Thio T does not affect the kinetics of the gelling
process, consistent with previous results on insulin aggre-
gation (31). Next, an experiment was conducted under iden-
tical conditions to those described above, using an instrument
specially designed to allow simultaneous detection of ﬂuo-
rescence and scattering from a single sample, thus relieving
any uncertainties arising from attempts to prepare two iden-
tical reaction mixtures. The values for the kinetic parameters
were in excellent agreement for the two detection modes. For
ﬂuorescence monitoring, kc ¼ 3.6 x 104 s1; n ¼ 11 and
m ¼ 1.6. A comparison of the two sets of kinetic
parameters—one for extinction and the one for ﬂuorescence
monitoring—leads us to conclude that the kinetic proﬁle and
measured rates for insulin gelling are the same regardless of
which detection mode is used to monitor the reaction.
Dependence on initial conditions
Insulin concentration
Kinetics of gelation was studied over a range of insulin con-
centrations between 30 and 400 mM (Fig. 2). At the lower
end of the range, the ﬁnal extinction values scale with insulin
concentration. However, the ﬁnal extinction value does not
change appreciably above ;100 mM insulin, even with
a fourfold increase in peptide concentration. Apparently,
aspects of the size, shape, and number density of the insulin
aggregates offset one another to produce ﬁnal mixtures of
comparable extinction. Selected gel samples throughout the
concentration range, when treated with Congo red and/or
Thioﬂavin T show the spectral changes characteristic of
b-amyloid assemblies. Complete kinetic analyses of these
data indicate that for all solutions, m ; 1, n ¼ 10 6 1, and
above ;50 mM insulin there is no dependence of the
catalytic rate constant on the initial insulin concentration;
kc ; 3.5 3 10
4 s1. Kinetic studies for subsequent experi-
ments were generally conducted at or near 200 mM insulin,
chosen for convenience.
pH dependence
Gelation kinetics were studied at 67 and 200 mM insulin in
a pH range between 1.17 and 1.69 (Fig. 3). As may be seen in
the ﬁgure: i), only very small increases in extinction were
observed over a 2-h period when the pH was above ;1.65;
FIGURE 1 Kinetic proﬁle for insulin gelation and the ﬁt provided by Eq. 2.
Extinction was measured at 488 nm on a standard spectrophotometer for
a solutionwhose initial conditionswere [Insulin]¼ 200mM,pH1.37 at 67C.
The best ﬁt was obtained for ko; 0; kc¼ 3.83 104 s1; n¼ 11 andm¼ 1.4.
FIGURE 2 Kinetic proﬁles of gel formation for insulin concentrations
between 30 and 400mM.Equation 3was adequate to ﬁt these data (m¼ 1) and
n¼ 106 1. For [Insulin]¼ 30mM, kc¼ 2.03 104 s1; [Insulin]¼ 50mM,
kc ¼ 2.53 104 s1 and for all higher concentrations, kc ¼ 3.53 104 s1.
FIGURE 3 Kinetic proﬁles for insulin gel formation at various pH values
(200 mM insulin, 67). As the pH decreases, the rate of aggregation and ﬁnal
extinction values increase, whereas the apparent lag time decreases.
1036 Pasternack et al.
Biophysical Journal 90(3) 1033–1042
and ii), the lag time decreases with decreasing pH from
;4200 s at higher pH to ;1400 s. Kinetic proﬁles retain
their sigmoidal form throughout the pH range studied, but
the sloped portion of the proﬁles become increasingly steep
with decreasing pH. Upon analysis using Eq. 2, the kinetic
parameters m and n show practically no dependence on pH
(m; 1.0–1.5; n; 116 1) but the catalytic rate constant (kc)
increases with increasing [H1], as shown in Fig. 4. That the
pH of the reaction mixture has a large effect on aggregation
kinetics is an important factor in experimental design. We
have found that different lots of crystalline insulin have
differing buffering capacities, and therefore careful adjust-
ment of pH is required to obtain reproducible results.
Ionic strength
The ionic strength dependence of the gelation rate was
determined by the addition of NaCl in a concentration range
between 0.011 and 0.16 M at a ﬁxed pH. For these studies,
a value of pH ; 1.62 proved convenient because the speed
and magnitude of the extinction increase markedly with ionic
strength. The experimentally determined value of kc under
these pH conditions in the absence of NaCl is 1.1 3 104
s1. The kinetic proﬁles all have a similar form throughout
the NaCl concentration range, with a shortened delay period
up to [NaCl] ¼ 0.10 M (Fig. 5). A plot of log kc versus I1/2/
(1 1 I1/2) is linear with a slope of 12.6 6 0.3.
A series of experiments were conducted in which various
electrolytes were added to the reaction mixture to determine
their impact on the kinetics at ﬁxed pH. Each of CuCl2,
CoCl2, and AlCl3 were tested. The concentrations of these
species were adjusted so as to produce a constant ionic
strength (0.060 M) in the reaction mixture. The results are
shown in Fig. 6; the presence of electrolytes enhances the
rate of gel formation. However, under constant ionic strength
conditions, these several electrolytes are nearly indistin-
guishable, but somewhat less effective at promoting the ag-
gregation than the 1:1 NaCl electrolyte at the same ionic
strength.
Inﬂuence of added porphyrins
Previous studies have indicated that a number of hydropho-
bic aromatic ring-containing drugs, including several por-
phyrins and phthalocyanines, are effective at inhibiting prion
FIGURE 4 Plot of the catalytic rate constant, kc versus [H
1] for the insulin
gelation reactions shown in Fig. 3. The slope of the line is 0.012 M1s1.
FIGURE 5 Overlay of normalized representative kinetic proﬁles for
insulin gelation at various ionic strengths (NaCl). Shown in the ﬁgure (from
right to left) are [NaCl] ¼ 0.050, 0.070, 0.10, and 0.15.The conditions were
200 mM insulin, pH 1.62, 67C. (Inset) Plot of log kc versus I1/2/(11 I1/2) for
insulin gelation in the presence of NaCl. The slope of the line is12.66 0.3,
indicating interaction between two species of like charge type.
FIGURE 6 Effect of added electrolytes on kinetics of insulin gelation.
Each of the salts (NaCl, CuCl2, CoCl2, and AlCl3) is added so as to make the
ﬁnal ionic strength 0.060M. The kinetics of gelation is always faster than for
a solution to which no electrolyte was added but the difference among
electrolytes is minor.
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protein formation both in vitro and in vivo (33,34). This
observation encouraged us to test water-soluble metal-
loporphyrin derivatives for possible inhibitory effects on
the kinetics of insulin gelation. A range of concentrations of
the Cu21, Ni21, Fe31, Mn31, Co31, and Au31 derivatives of
the cationic tetrakis(N-methylpyridinium-4-yl)porphine (MT4)
and anionic tetrakis(4-sulfonatophenyl)porphine (MTPPS)
were included in the reaction mixture and the extinction was
monitored at 620 nm where metalloporphyrin absorption
does not contribute appreciably. A marked dependence of
inhibitory inﬂuence on charge type of the metalloporphyrin
was observed. Whereas the MT4 cationic porphyrins have no
signiﬁcant impact on the kinetics of gelation of insulin
regardless of the metal derivative used, all MTPPS metal-
loporphyrins show inhibitory effects, with the efﬁciency and
mechanism of inhibition dependent on metal derivative and
concentration.
For all of FeT4, MnT4, CoT4, AuT4, and NiT4 at
a concentration of 1 3 105 M, the values of the critical
kinetic parameters were m ; 1; n ¼ 12 6 1; kc ¼ 3.6 6 0.6
3 104 s1 as compared to n ¼ 11 and kc ¼ 3.4 3 104 s1
for the porphyrin-free solution, as run in this series of ex-
periments (Fig. 7). Results for CuTPPS at several concen-
trations are included in the ﬁgure for comparison. At
concentrations below 106 M CuTPPS, reaction proﬁles
retain the lag period/growth burst form similar to the control
proﬁle (no porphyrin), although the onset of the rapid growth
phase is shifted to longer times. To determine whether the
growth portion of the proﬁle is affected by the presence of
CuTPPS in this submicromolar concentration range, the
control proﬁle was moved through a time increment equi-
valent to the extension of the delay period as shown in Fig. 8
A for 5 3 107 M metalloporphyrin. After shifting the
control (in this case by some 8000 s), the normalized proﬁle
is nearly identical to that obtained in the presence of por-
phyrin. Apparently the growth phase is essentially unaltered
by the presence of low concentrations of CuTPPS, whereas
the lag period is signiﬁcantly prolonged.
We attempted experiments that would demonstrate whether
the rapid growth process can be postponed, reversed, or eli-
minated by timely incremental additions of CuTPPS. Kinetic
runs were conducted in which the concentration of CuTPPS
(initially at 33 107 M) was doubled during the rapid rise in
extinction or during the delay period. Doubling the CuTPPS
concentration during the growth phase had no effect on the
continuation of that part of the process. Likewise, rapid
FIGURE 7 Insulin gelation kinetics in the presence of added metal-
loporphyrins. None of the metal derivatives of H2T4 inﬂuenced either the lag
time or growth rate appreciably. An experiment conducted under the same
conditions but without added metalloporphyrin is shown for comparison (n).
In contrast, the copper(II) derivative of H2TPPS has a marked inﬂuence on
the kinetic proﬁle that depends on CuTPPS concentration.
FIGURE 8 (A) The kinetic proﬁle for insulin gelation in the absence of
metalloporphyrin is shifted by 8000 s to compare to the proﬁle in the
presence of 5 3 107 M CuTPPS. The growth phase of the proﬁle is
unaffected by the presence of the metalloporphyrin. (B) Kinetic proﬁle for
insulin gelation in the presence of 1 3 106 M CuTPPS. The lag period is
now extended to some 20,000 s after which two successive growth patterns
are observed; one characteristic of high CuTPPS concentrations followed by
the low-concentration growth proﬁle.
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growth was unaffected when the CuTPPS concentration was
doubled during the delay period. However, the delay period
itself was shortened to ;2500 s when the CuTPPS concen-
tration was doubled during this phase; this shortening of the
‘‘lag time’’ was shown to be a result of agitating the reaction
mixture to insure thorough mixing as additional CuTPPS
was added. This effect was further probed by vortexing a
mixture that, unperturbed, would have had a greatly ex-
tended lag time. At 3 3 107 and 5 3 107 M CuTPPS, the
delay periods were shortened to approximately that of a
control proﬁle (;2500–3000 s) when the reaction was sub-
jected to vortexing at periodic intervals. Thus, at low con-
centrations of CuTPPS the lag time is prolonged through an
interaction that can be disrupted by mechanical agitation of
the reaction mixture. It is worth noting, however, that this
delay period at low concentrations of CuTPPS is never
shortened to less than that of a control proﬁle.
Above a concentration of 3 3 106 M CuTPPS, a very
different set of observations is made (Type II behavior).
First, very little gel forms as indicated by the relatively low
values of the extinction obtained after hours (or days) of
waiting. Very small quantities of gel can be separated upon
centrifugation. Second, as can be seen in Fig. 7 for [CuTPPS]
¼ 1 3 105 M, a scattering signal—albeit small—is ob-
served beginning at t ¼ 0; i.e., there is no delay period. The
proﬁle appears very simple and, in fact, is ﬁt satisfactorily as
a ﬁrst-order process with a rate constant, k9 ; (2.5–3.0) 3
104 s1, a value that is comparable to the rate constant
obtained from autocatalytic ﬁts under these conditions of pH
and temperature. A concentration of 1 3 106 M CuTPPS
seems to represent a transition between the low and high
concentration mechanisms (see Fig. 8 B). After an incubation
period of .20,000 s, the initial rise in extinction is slow but
at;30,000 s, rapid growth begins. The proﬁle shown in Fig.
8 B appears to be the result of two (or more) reaction path-
ways.
Emission by Thioﬂavin T was used for detection in a set of
kinetic experiments in both the low and high CuTPPS con-
centration regimes. Recall that monitoring Thio T emission
over time can provide insight as to the rate-determining step
of the reaction because Thio T reports the presence of
protoﬁbrils, thus allowing detection of intermediates in the
overall gelation process. At low concentrations of CuTPPS,
the proﬁle was the same as that measured by extinction. The
same observation was made at higher concentration but very
little gel was produced and, therefore, little ﬂuorescent en-
hancement was observed. The amyloid nature of the gel at
high CuTPPS concentration was conﬁrmed by testing an
accumulated product of several runs with Thio T and CR. The
characteristic enhancement and maxima shifts were observed
and, therefore, the gels formed with 105 M CuTPPS are
amyloid in nature. In summary, two types of behavior are
observed for kinetic studies of insulin aggregation in the
presence of CuTPPS. At low concentration of CuTPPS, the
delay period is extended and the ﬁnal extinction is increased,
but the slope of the growth phase is similar to that of a control
proﬁle. At high CuTPPS concentration, the kinetic proﬁles
have a ﬁrst-order dependence on time with a rate constant
that is of the order of the catalytic rate constants of an insulin
control experiment, ﬁt with the autocatalytic model. The
transition concentration for these two types of behavior is
;106 M.
Other metal derivatives
The iron(III) derivative of TPPS is also inhibitory but
exhibits somewhat different behavior from that of CuTPPS.
In general, FeTPPS is a less efﬁcient inhibitor than is
CuTPPS. At 106 M FeTPPS, the delay period is extended
from that of the control proﬁle by ;2800–3000 s (see Table
2), compared to.15,000 s for a reaction mixture containing
106 M CuTPPS. At concentrations .106 M FeTPPS, the
lag and rapid growth phases are still observed, with delay
periods extended to somewhat longer times. Type II
behavior, seen with high concentrations of CuTPPS, is not
observed at or below 105 M FeTPPS. To determine if the
growth phase of FeTPPS-containing reaction mixtures are
signiﬁcantly different from the growth phase of a control
proﬁle, overlays of a shifted control were made with the 13
106 and 3 3 106 M FeTPPS proﬁles. As for CuTPPS the
proﬁles are almost identical. When a reaction mixture con-
taining 106 M FeTPPS was vigorously agitated on a vortex
mixer, practically no change is observed in the lag time of the
proﬁle. Unlike the situation for CuTPPS vigorous agitation
does not affect the inhibitory effects of FeTPPS on ﬁbril
formation.
Preliminary experiments were conducted with other
metalloderivatives of TPPS; Au(III), Co(III), Ni(II), and
Mn(III)TPPS were all tested for their inhibitory effects. The
concentration dependence of AuTPPS is similar to that of
FeTPPS, though as shown in Table 2, AuTPPS is slightly
more efﬁcient than the iron derivative at extending the delay
period. Kinetic proﬁles were recorded for AuTPPS concen-
trations between 106 and 105 M. At 106 M, the delay
period is extended to ;7600 s and the ﬁnal extinction is
greater than for a control proﬁle. At 3 3 106 M AuTPPS,
the delay period is .48,000 s. This pattern is similar to that
of FeTPPS, in that all of the proﬁles indicate lag period/
TABLE 2 Comparison of delay times for several
metalloderivatives of tetrakis(4-sulfonatophenyl)porphine
Delay period (s)
Concentration (mM) CuTPPS FeTPPS AuTPPS
0 2000–2500 2000–2500 2000–2500
0.1 2400 — —
0.3 5000 — —
0.5 10,000 — —
1.0 20,000 5,100 7,600
3.0 Type II 35,000 .48,000
10 Type II .50,000 —
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growth burst kinetics rather than Type II behavior observed
at higher concentrations of CuTPPS. A vortexing experiment
shows that AuTPPS has a weak interaction with intermedi-
ates similar to that of CuTPPS, but unlike FeTPPS. The delay
period of a 106 M AuTPPS reaction mixture that was
vortexed every 500 s is ;4000 s, compared with 7600 s for
an unvortexed reaction mixture. This decrease in delay
period is not as dramatic as for CuTPPS, for which agitation
consistently lowers the lag time to that of a control proﬁle.
The disruption of inhibition by vortexing of AuTPPS and
CuTPPS—but not the FeTPPS—suggests that axial ligation
(typical of the iron(III) derivative) may contribute to the gel-
binding or general interference ability of the metallopor-
phyrin. Limited concentration studies on CoTPPS, NiTPPS,
and MnTPPS indicate that each porphyrin has a similar
inhibitory effect as either CuTPPS or FeTPPS, though the
efﬁciency of the inhibition varies with the metal. Additional
studies are required before a correlation can be made be-
tween speciﬁc porphyrin properties and their inﬂuence on gel
formation.
DISCUSSION
Conversion of soluble insulin into insoluble amyloid-type
gels is a multistep process involving alteration of the pep-
tide’s secondary structure (13) and aggregation, ﬁrst into
protoﬁbrils and then into ﬁbrils (18). At acidic pH at room
temperature, insulin exists as small oligomers of native-like
a-helical molecules (14) containing disulﬁde bridges that are
retained in the product ﬁbrils (19). The predominant solute
species at pH ; 2 (HCl) at room temperature is reported to
be the dimer (15). At high temperature, the dimer dissociates
in the presence of acid and undergoes a structural change,
resulting in the formation of assemblies of a nonnative in-
sulin structure (rich in b-sheets) (13). The process involves
a partial unfolding of the peptide monomer leading to the
exposure of nonpolar side chains to the solvent, which pro-
motes self-assembly (18).
Experimental results presented here make apparent—even
without the application of a kinetic model—that the rate-
determining step in this overall pathway comes early in the
process. Kinetic proﬁles obtained via extinction detection are
virtually identical to those measured by ﬂuorescence en-
hancement of added Thioﬂavin T. Because the Thio T ﬂuo-
rophore recognizes and reports the presence of protoﬁbrils,
the slow step in the mechanism must precede ﬁbril forma-
tion. In fact, our results suggest that the rate-determining step
occurs at a still earlier stage in the reaction pathway. The
nonconventional autocatalytic model of Eqs. 1–3 has been
successfully applied to the kinetic data for insulin gel for-
mation (Fig. 1). In this approach, the surface of the aggre-
gated product is proposed to catalyze the rate-determining
step for the conversion of the soluble insulin reactant into the
insoluble amyloid-type ﬁbril. The value of the m parameter
(which in the model deﬁnes the total number of insulin
reactant species participating in the rate-determining step)
approaches unity in our experiments. This result parallels the
conclusion reached earlier that application of this kinetic
model to data for the gelation of OsmB protein provides a
‘‘seed size’’ of about one, and is consistent with the em-
pirical ﬁnding by Shinozaki et al. that data for the formation
of amyloid ﬁbrils formed by amyloid-b-proteins can be ﬁt
with a stretched exponential (Eq. 3) (35). A value of m ¼ 1
implies that the rate-determining step is the activation of the
reactant rather than its assembly into a critical nucleus or
seed. Certainly, molecular assembly is involved in the gel-
ling process but, according to our kinetic results (and
therefore subject to the applicability of the model), the rate-
determining step precedes an aggregation process, even of
small arrays. Studies on the in vitro conversion of mam-
malian prion protein into ﬁbrils have also been interpreted
as involving a rate-limiting conformational rearrangement of
polypeptides (36).
In summary, a suggested sequence for insulin gelling
begins with the insulin dimer (D), which is reported as the
stable form of the peptide in acidic solution (HCl) at room
temperature (15):
ðiÞD1H1MH1 1M ðk1; k1Þ
ðiiÞM1H1MH1 ðk2; k2Þ
ðiiiÞMH1 1 ðMH1 Þn1/ðMH1 Þn ðk3Þ:
Upon heating, the dimer dissociates into monomers with
the involvement of a proton (Fig. 4) that perhaps serves to
interfere with hydrogen bonding or other weak interactions
between the monomeric units. In this step (i), MH1 rep-
resents a partially unfolded, structurally modiﬁed protonated
insulin monomer that aggregates (step (iii)). The free mono-
mer (M) that also forms in step (i) becomes protonated to
yield MH1 (step (ii)). This three-step mechanism is con-
sistent with the proposal that insulin ﬁbril formation pro-
ceeds through a monomeric form (31,37). If included in
this mechanistic argument is catalysis of step (i) by the gel
surface, the result is a rate-determining step involving an
autocatalyzed activation of insulin solute species. A key
event in the aggregation process is the attack of a proton
on the cationic peptide dimer, a reaction whose rate is ex-
pected to increase with increasing ionic strength, as shown in
Fig. 5.
Because the gelation of peptides in general is likely to
involve charged species, it is important to consider ionic
strength effects when evaluating the kinetic impact of added
metal salts. For this system CoCl2, CuCl2, and AlCl3 are
nearly indistinguishable when present at the same ionic
strength, and just slightly less effective at promoting aggre-
gation than is NaCl (Fig. 6). However, considerable evidence
exists that when considering authentic prion protein aggre-
gation, speciﬁc electrolyte effects exist for these and similar
salts (38). Our result points out a limitation of using insulin
gelation at low pH as a model system for the formation of
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amyloid ﬁbrils in vivo. The low pH conditions used here
likely interfere with the binding of these metal ions to side
chains of amino acid moieties, and thus the metal salt in-
ﬂuence is restricted to a general electrolyte effect arising
from the partial neutralization of like-charged interacting
species. However, this result underscores the necessity of
considering general electrolyte effects as well as speciﬁc
interactions when studying the inﬂuence of metal ions on the
aggregation rates of authentic prion proteins. We are cur-
rently investigating speciﬁc anion effects for the insulin sys-
tem, and especially as a consequence of our ﬁndings with
metalloporphyrins.
The effect of added metalloporphyrins on the rate of
gelation can be considered in the context of the proposed
mechanism described above. None of the tested cationic
porphyrins showed any signiﬁcant inﬂuence on the reaction
kinetics, and this we believe is due largely to Coulombic
effects. The aggregating peptide is cationic and the large
positive charge on the MT4 species effectively prevents any
direct interaction with the fully protonated insulin molecule.
That is not to say that these metalloporphyrins may not be
effective inhibitors for other protein aggregations, but ap-
parently not when the peptide is carrying a large positive
charge. On the other hand, all the anionic MTPPS species
tested inﬂuence insulin gelling kinetics.
The copper(II) derivative, CuTPPS, shows two types of
inhibitory behavior depending on concentration. In the lower
concentration range, CuTPPS extends the lag time before the
growth phase of the aggregation process, but has no effect on
the rate of the growth phase itself. Furthermore, the
inhibition by CuTPPS can be disrupted by agitation when
the metalloporphyrin is present at low concentration (,106
M). It is likely that there is a weak interaction between
CuTPPS and small ﬁbril intermediates preventing the
formation of a clean, catalytic surface for additional mono-
merization/conformational change of insulin. However,
eventually the CuTPPS supply is exhausted and the amyloid
formation process continues as if no CuTPPS were present,
albeit at a later time; the delay timescales with metal-
loporphyrin concentration. The small, precursor catalytic
structure (small enough not to scatter light appreciably) is
thus ‘‘poisoned’’ by the metalloporphyrin. However, upon
agitation, previously interior peptide molecules create new
surfaces that then lead to the structures responsible for ca-
talysis. All of the MTPPS derivatives tested show this
behavior with varying efﬁciency and precursor stability,
depending upon the metal incorporated into the porphine
structure. Interestingly, the diacid form of TPPS (H4TPPS
2)
at this concentration level has no effect on either delay time
or growth rate. Again, Coulombic effects may be playing
a role; the porphyrin diacid involves a buildup of positive
charge at the core of the porphine unit. However, the pres-
ence of the metal-free derivative at high concentration
(;105 M) does have a profound impact on the morphology
of the formed aggregate; for this derivative the insulin gel
(now green with adsorbed porphyrin diacid) settles out
almost completely without any need for centrifugation.
CuTPPS shows a second type of behavior at higher con-
centrations shared by only a small number of the metal-
loderivatives. A sufﬁciently high concentration of CuTPPS
markedly decreases the amount of gel produced. CuTPPS
self-aggregates to form dimers (as does NiTPPS) in this
higher concentration range, and it is possible that this dimeric
porphyrin structure serves as a catalyst for gel formation. The
lag time disappears at these metalloporphyrin concentrations
and the rate constant is comparable to kc but under these
conditions, the product gel is sufﬁciently contaminated that
even on agitation there is no tendency for the peptide to
undergo the explosive growth phase characteristic of the re-
action proﬁle in the absence of inhibitors. At an intermediate
concentration of CuTPPS both behaviors are observed for a
single sample providing a reaction proﬁle of considerable
complexity.
In summary, we suggest that the rate-determining step for
the formation of amyloid-type gels of insulin involves the ac-
tivation of the solute species of the peptide rather than ‘‘seed’’
formation. This process, which can be modeled effectively as
being catalyzed by insulin aggregates, has marked temper-
ature and ionic strength dependences. Metalloporphyrins
hold considerable promise as inhibitors of assembly kinetics,
and in vitro studies can be helpful in determining the par-
ticular derivatives and concentration conditions needed to
maximize their impact. Our results indicate that the overall
charge of the porphyrin as well as the oxidation state and
ligand-binding tendencies of the incorporated metal all play
a role in tuning the efﬁciency of inhibition.
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